G. A. Smith

831 total citations
32 papers, 629 citations indexed

About

G. A. Smith is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience. According to data from OpenAlex, G. A. Smith has authored 32 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Cognitive Neuroscience. Recurrent topics in G. A. Smith's work include Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Neural and Behavioral Psychology Studies (4 papers). G. A. Smith is often cited by papers focused on Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Neural and Behavioral Psychology Studies (4 papers). G. A. Smith collaborates with scholars based in Australia, United States and Tanzania. G. A. Smith's co-authors include Neil Brewer, Gina Geffen, L. B. Geffen, Nicholas G. Martin, Margaret J. Wright, Michelle Luciano, Mervyn J. Eadie, Kathleen M. Giacomini, Pierre Schulz and Terrence F. Blaschke and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

G. A. Smith

30 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. A. Smith Australia 13 149 145 123 113 87 32 629
Howard Schachter Canada 15 109 0.7× 304 2.1× 31 0.3× 68 0.6× 32 0.4× 29 1.0k
Kathleen Maloney United States 16 223 1.5× 140 1.0× 104 0.8× 164 1.5× 86 1.0× 30 910
José Cañete Spain 11 120 0.8× 210 1.4× 64 0.5× 62 0.5× 80 0.9× 28 501
Salima Punja Canada 13 88 0.6× 165 1.1× 45 0.4× 48 0.4× 37 0.4× 27 543
Gary M. Levin United States 15 84 0.6× 399 2.8× 54 0.4× 118 1.0× 153 1.8× 33 794
Felix Klajner Canada 12 103 0.7× 49 0.3× 129 1.0× 60 0.5× 51 0.6× 16 1.1k
Jessica R. Oesterheld United States 13 36 0.2× 125 0.9× 38 0.3× 204 1.8× 53 0.6× 25 643
In-Hee Cho South Korea 13 86 0.6× 217 1.5× 91 0.7× 32 0.3× 40 0.5× 35 634
Paul Crichton United Kingdom 7 148 1.0× 140 1.0× 30 0.2× 23 0.2× 20 0.2× 20 442
Eleanor Bathory United States 6 69 0.5× 63 0.4× 155 1.3× 91 0.8× 56 0.6× 7 425

Countries citing papers authored by G. A. Smith

Since Specialization
Citations

This map shows the geographic impact of G. A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. A. Smith more than expected).

Fields of papers citing papers by G. A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. A. Smith. The network helps show where G. A. Smith may publish in the future.

Co-authorship network of co-authors of G. A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of G. A. Smith. A scholar is included among the top collaborators of G. A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. A. Smith. G. A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lickliter, Jason D., G. A. Smith, Matthew Burge, et al.. (2010). Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. British Journal of Cancer. 103(5). 597–606. 23 indexed citations
3.
Lickliter, Jason D., G. A. Smith, Matthew Burge, et al.. (2007). Phase I study of CYT997, a novel cytotoxic and vascular disrupting agent, given as a 24-hour intravenous infusion to patients with advanced solid tumours. Journal of Clinical Oncology. 25(18_suppl). 14115–14115. 2 indexed citations
4.
Smith, G. A., et al.. (2005). Psychological symptoms and nonfatal unintentional injuries among Chinese adolescents: a prospective study. Journal of Adolescent Health. 37(6). 460–466. 34 indexed citations
5.
Hansell, Narelle K., Margaret J. Wright, Gina Geffen, et al.. (2001). Genetic Influence on ERP Slow Wave Measures of Working Memory. Behavior Genetics. 31(6). 603–614. 33 indexed citations
6.
Luciano, Michelle, Margaret J. Wright, G. A. Smith, et al.. (2001). Genetic Covariance Among Measures of Information Processing Speed, Working Memory, and IQ. Behavior Genetics. 31(6). 581–592. 122 indexed citations
7.
Zubicaray, Greig I. de, et al.. (1997). Deficits on self ordered tasks associated with hyperostosis frontalis interna. Journal of Neurology Neurosurgery & Psychiatry. 63(3). 309–314. 1 indexed citations
8.
Millérioux, L, et al.. (1995). Determination of ceftiofur and its desfuroylceftiofur-related metabolites in swine tissues by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 673(2). 231–244. 42 indexed citations
9.
Smith, G. A., et al.. (1984). Pre- and Posterror Responding in Serial Choice Tasks: Evidence for Trial-by-Trial Tracking. Perceptual and Motor Skills. 58(3). 1007–1010. 1 indexed citations
10.
Brewer, Neil & G. A. Smith. (1984). How normal and retarded individuals monitor and regulate speed and accuracy of responding in serial choice tasks.. Journal of Experimental Psychology General. 113(1). 71–93. 56 indexed citations
11.
Smith, G. A., et al.. (1984). Observer Reactivity in Monitored and Unmonitored Analogue Conditions. Journal of Psychoeducational Assessment. 2(3). 249–255. 2 indexed citations
12.
Smith, G. A., Pierre Schulz, Kathleen M. Giacomini, & Terrence F. Blaschke. (1982). High-Pressure Liquid Chromatographic Determination of Amitriptyline and Its Major Metabolites in Human Whole Blood. Journal of Pharmaceutical Sciences. 71(5). 581–583. 22 indexed citations
13.
Howell, E.R., G. A. Smith, & Gordon Stanley. (1981). Reading disability and visual spatial frequency specific effects. Australian Journal of Psychology. 33(1). 97–102. 12 indexed citations
14.
Smith, G. A., et al.. (1979). Factors Influencing Plasma Concentrations of Ethosuximide. Clinical Pharmacokinetics. 4(1). 38–52. 12 indexed citations
15.
Smith, G. A., W. D. Hooper, J. H. Tyrer, M. J. Eadie, & Brian J. Werth. (1979). The comparative bioavailability of carbamazepine in 100 mg and 200 mg tablets. Clinical and Experimental Pharmacology and Physiology. 6(1). 37–40. 1 indexed citations
16.
Eadie, Mervyn J., et al.. (1977). The pharmacokinetics of carbamazepine. European Journal of Clinical Pharmacology. 12(6). 451–456. 36 indexed citations
17.
Smith, G. A.. (1977). Voice analysis for the measurement of anxiety. British Journal of Medical Psychology. 50(4). 367–373. 32 indexed citations
18.
Schonfield, David & G. A. Smith. (1976). SEARCHING FOR MULTIPLE TARGETS AND AGE. Educational Gerontology. 1(2). 119–129. 1 indexed citations
19.
Smith, G. A., et al.. (1975). The bioavailability of carbamazepine.. Europe PMC (PubMed Central). 12. 123–8. 9 indexed citations
20.
Hooper, W. D., et al.. (1975). Plasma protein binding of carbamazepine. Clinical Pharmacology & Therapeutics. 17(4). 433–440. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026